Variability of clinically measured lung clearance index in children with cystic fibrosis-Reference-Cited by-同舟云学术

Variability of clinically measured lung clearance index in children with cystic fibrosis

Published:2022-11-02 Issue:1 Volume:58 Page:197-205
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Frauchiger Bettina S.¹^ORCID,Ramsey Kathryn A.¹,Usemann Jakob²³^ORCID,Kieninger Elisabeth¹,Casaulta Carmen¹^ORCID,Sirtes Daniel¹,Yammine Sophie¹^ORCID,Spycher Ben⁴,Moeller Alexander²^ORCID,Latzin Philipp¹

Affiliation:

1. Department of Pediatrics, Division of Pediatric Respiratory Medicine, Inselspital, Bern University Hospital University of Bern Bern Switzerland

2. Division of Respiratory Medicine and Children's Research Center University Children's Hospital Zurich Zurich Switzerland

3. University Children's Hospital Basel (UKBB) Basel Switzerland

4. Institute of Social and Preventive Medicine University of Bern Bern Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Vertex Pharmaceuticals

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26180

Reference44 articles.

1. Multiple-Breath Washout as a Marker of Lung Disease in Preschool Children with Cystic Fibrosis

2. Multiple-Breath Washout Outcomes Are Sensitive to Inflammation and Infection in Children with Cystic Fibrosis

3. Elevated lung clearance index in infants with cystic fibrosis shortly after birth

4. Lung Clearance Index and Structural Lung Disease on Computed Tomography in Early Cystic Fibrosis

5. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric pulmonology year in review 2023: Physiology;Pediatric Pulmonology;2024-03-28

2. Lung clearance index (LCI_2.5) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The “real‐world” differs from trial data;Pediatric Pulmonology;2024-02-28

3. Impact of Reanalysis of Nitrogen Multiple-Breath Washout on its Relationship with Chest Magnetic Resonance Imaging Findings in Clinically Stable and Pulmonary Exacerbated Children with Cystic Fibrosis;Klinische Pädiatrie;2023-12-18

4. Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis;International Journal of Molecular Sciences;2023-08-02